You have 9 free searches left this month | for more free features.

Oxaliplatin

Showing 2551 - 2575 of 2,879

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS, Acute Myeloid Leukemia, Leukemia Trial in Houston (Oxaliplatin, Fludarabine, Cytarabine)

Terminated
  • Myelodysplastic Syndromes
  • +2 more
  • Oxaliplatin
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 1, 2012

Cancer of the Gallbladder, Cancer of the Biliary Tract Trial in Houston (Capecitabine, Oxaliplatin)

Completed
  • Cancer of the Gallbladder
  • Cancer of the Biliary Tract
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Jul 27, 2012

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery

Completed
  • Peritoneal Mesotheliomas
  • Cytoreductive surgery and HIPEC
  • Montréal, Quebec, Canada
    Maisonneuve Rosemont Hospital
Mar 15, 2013

Liver Cancer, Advanced Solid Tumors Trial in Houston (Fluorouracil, Avastin, Leucovorin)

Completed
  • Liver Cancer
  • Advanced Solid Tumors
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Jul 26, 2012

Pancreatic Cancer Trial (ICT of oxapliplatin, irinotecan, leucovorin, and fluorouracil and CCRT, ICT of

Unknown status
  • Pancreatic Cancer
  • ICT of oxapliplatin, irinotecan, leucovorin, and fluorouracil and CCRT
  • ICT of Gemcitabine,oxapliplatin, leucovorin, and fluorouracil + CCRT
  • (no location specified)
May 27, 2013

Anal, Colon, and Rectal Cancers, Colorectal Tumors, Colon/Rectal Cancer Trial in Stanford (Vandetanib, Capecitabine,

Completed
  • Anal, Colon, and Rectal Cancers
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
Jul 12, 2012

Refractory Aggressive Non-Hodgkin's Lymphoma, Relapsing Aggressive Non-Hodgkin's Lymphoma Trial (Rituximab, Gemcitabine,

Completed
  • Refractory Aggressive Non-Hodgkin's Lymphoma
  • Relapsing Aggressive Non-Hodgkin's Lymphoma
  • Rituximab, Gemcitabine, Oxaliplatin
  • (no location specified)
Jul 11, 2012

Unknown Primary Tumors Trial in Houston (Gemcitabine (Gemox), Oxaliplatin, Questionnaire)

Completed
  • Unknown Primary Neoplasms
  • Gemcitabine (Gemox)
  • +2 more
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Aug 1, 2012

Breast Cancer Trial in Worldwide (oxaliplatin)

Terminated
  • Breast Cancer
  • oxaliplatin
  • Vienna (Wien), Austria
  • +9 more
Jul 23, 2012

Colorectal Liver Metastases Trial in Houston (5-Fluorouracil, Bevacizumab, Leucovorin)

Terminated
  • Colorectal Liver Metastases
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Jul 27, 2012

Colorectal Cancer Trial in Beijing (Oxaliplatin, Xeloda, Calcium folinate (CF))

Unknown status
  • Colorectal Cancer
  • Oxaliplatin
  • +4 more
  • Beijing, China
    Cancer Institute&Hospital Chinese Academy of Medical Sciences
Sep 5, 2012

Gastrointestinal Cancer Trial in Xijing (S-1 plus oxaliplatin)

Unknown status
  • Gastrointestinal Cancer
  • S-1 plus oxaliplatin
  • Xijing, Shanxi, China
    Xijing hospital of the fourth military medical univercity
May 28, 2012

Colon Cancer Liver Metastasis Trial (Bevacizumab)

Withdrawn
  • Colon Cancer Liver Metastasis
  • (no location specified)
May 28, 2013

Liver Metastases, Colorectal Cancer Trial in Harbin, Shenyang (bevacizumab plus chemo)

Unknown status
  • Liver Metastases
  • Colorectal Cancer
  • bevacizumab plus chemotherapy
  • Harbin, Heilongjiang, China
  • +1 more
Jan 28, 2013

Colorectal Cancer Trial in San Antonio (oblimersen sodium, fluorouracil, leucovorin calcium)

Completed
  • Colorectal Cancer
  • oblimersen sodium
  • +3 more
  • San Antonio, Texas
    San Antonio Cancer Institute
Jul 3, 2012

Colorectal Cancer, KRAS Wildtype, After Resection of Liver Metastases Trial in Munich (Folic Acid, 5-FU, Oxaliplatin)

Unknown status
  • Colorectal Cancer
  • +2 more
  • Folic Acid
  • +3 more
  • Munich, Germany
    Ludwig-Maximilians - University of Munich
Jul 5, 2012

Advanced Biliary Cancer Trial in Villejuif (Gemox, Cetuximab)

Completed
  • Advanced Biliary Cancer
  • Gemox, Cetuximab
  • Villejuif, France
    Institut Gustave Roussy
Jun 12, 2012

Enumeration of Circulating Tumor Cells in Rectal Cancer

Unknown status
  • Rectal Cancer
  • radiation therapy
  • capecitabine (625mg/m2,bid,d1-5 qw)and oxaliplatin (85mg/m2 d1 qw)
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 21, 2012

Colorectal Cancer Trial in Switzerland (Capecitabine, irinotecan HCl, oxaliplatin)

Completed
  • Colorectal Cancer
  • Chur, Switzerland
  • +3 more
Jun 2, 2012

Colorectal Cancer Trial in Cleveland (bevacizumab, erlotinib HCl, fluorouracil)

Completed
  • Colorectal Cancer
  • bevacizumab
  • +4 more
  • Cleveland, Ohio
  • +2 more
Aug 31, 2012

Colorectal Cancer Trial in Switzerland (capecitabine and oxaliplatin + cetuximab, capecitabine and oxaliplatin)

Completed
  • Colorectal Cancer
  • capecitabine and oxaliplatin + cetuximab
  • capecitabine and oxaliplatin
  • Aarau, Switzerland
  • +17 more
Jun 4, 2012

Metastatic Colorectal Cancer Trial in Austria, Germany (CY-503, Placebo)

Terminated
  • Metastatic Colorectal Cancer
  • Hall in Tirol, Austria
  • +32 more
Jul 9, 2013

Rectal Cancer, Gastric Cancer, Bone Marrow Toxicity Trial in Beijing (Bone Marrow-sparing Intensity-Modulated Radiotherapy)

Unknown status
  • Rectal Cancer
  • +3 more
  • Bone Marrow-sparing Intensity-Modulated Radiotherapy
  • Beijing, Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
May 28, 2013

Gastric Adenocarcinoma Trial in Beijing (Oxaliplatin+S-1, Adjuvant Oxaliplatin/S-1(SOX))

Unknown status
  • Gastric Adenocarcinoma
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Apr 23, 2012

Colorectal Cancer Trial in United States (bevacizumab, fluorouracil, leucovorin)

Completed
  • Colorectal Cancer
  • bevacizumab
  • +3 more
  • Little Rock, Arkansas
  • +162 more
Jan 16, 2013